Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex vs Bevacizumab for Macular Edema After Plaque Radiotherapy of Uveal Melanoma
NCT01471054Phase 2Terminated
- Sponsor
- Arman Mashayekhi
- Start
- Apr 2014
- Primary completion
- Jul 2015
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ozurdex in macular edema, Radiation Maculopathy (RM), radiation retinopathy (RR), sponsored by Arman Mashayekhi. Started Apr 2014; status: terminated.
02
Drugs
ozurdex
03
Conditions
macular edemaRadiation Maculopathy (RM)radiation retinopathy (RR)
Beyond the preview
Go deeper on NCT01471054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471054.